SYSTEM AND METHOD FOR ASSISTING IN THE HOME TREATMENT OF A MEDICAL CONDITION

• US 20120158424A1
• Filed: 07/22/2011
• Published: 06/21/2012
• Est. Priority Date: 05/15/2002
• Status: Abandoned Application

• Current Assignee: Novo Nordisk A/S
• Original Assignee: Novo Nordisk A/S
• Inventors: KNUDSEN, JENS BJERRE, Shapiro, Amy D.
• Application Number:
  US13/188,661
• Publication Number:
  US 20120158424A1
• Time in Patent Office: Days
• US Class Current: 705/2
• CPC Class Codes: A61B 5/4833 Assessment of subject's compliance to treatment
• CPC Class Codes: G06Q 10/06 Resources, workflows, human or project management; Enterprise or organisation planning; Enterprise or organisation modelling
• CPC Class Codes: G16H 10/60 for patient-specific data, e.g. for electronic patient records
• CPC Class Codes: G16H 20/17 delivered via infusion or injection
• CPC Class Codes: G16H 40/67 for remote operation
• CPC Class Codes: Y02A 90/10 Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation

Abstract

An interactive home treatment system and method is disclosed. Patient data is collected via a handheld device and stored in a database. The data may be related to self-treatments, symptoms, or patient behavior. The data are analyzed with an analytic tool and the analysis is used to generate a message that is transmitted to a treating health care professional or to the patient, or both. A set of predetermined rules may be applied to the data. The rules may be modified by the treating health care professional, the patient, or both. The handheld device, the database, and the analytic tool may be web-enabled to facilitate communication from virtually anywhere.

Claims

1. A method of transmitting information about a bleeding disorder to a healthcare provide for use with one or more patients having bleeding disorders, the method comprising the steps of:

providing the patient with a handheld device having a monitor with a touch screen and a processor;

displaying on the monitor a question indicative of whether the patient has taken a hemostatic medication prior to a bleeding episode;

receiving an answer from the patient as to whether a medication was administered before the bleeding episode began;

displaying on the monitor a question indicative of the time from the initial occurrence of the bleeding episode to the time of an infusion of an hemostasis product;

receiving an answer from the patient as to the time of the bleeding episode to the infusion;

displaying on the screen one or more pictures of the human body;

instructing the patient to indicate where bleeding is occurring by touching the picture in a location representative of the actual bleed;

receiving from the patient information as to the patients response to the infusion;

transmitting from the handhand held device to a centralized database at a location accessible to a healthcare provider information relating to location of the bleeding episode, time from onset of the bleeding episode to infusion, response to the infusion.

2. The method of claim 1 further comprising registering information about infusions of hemostasis agents from one of the patients having a bleeding disorder, wherein the information is entered via the handheld device and wherein the information entered comprises on or more of the following:

reasons for an infusion of a hemostasis product, number of infusions given in a predetermined time period, or number of bleeding episodes since last infusion of a hemostasis product.

3. The method of claim 1 where the patient is instructed to operate the device contemporaneously with a bleeding episode.

4. A system for collecting data relating to treating a patient having a bleeding disorder, the system comprising a handheld device having a touch screen display that displays one or more figures of the human body, an input mode for allowing a patient to enter location of a bleed by touching a corresponding part on the figure of the human body, the input mode allowing for entry of data relating to time from bleed to start of infusion of a self-administered hemostasis product and the input mode allowing for input of data relating to the success of the infusion in affecting the bleed, the system being configured to transmit data collected by the handheld device from the patient to a centralized processor, the centralized processor configured to compile data from multiple handheld devices.